Telix Pharmaceuticals Ltd
F:T3X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Delta Lithium Ltd
ASX:DLI
|
AU |
Wall St Price Targets
T3X Price Targets Summary
Telix Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for T3X is 15.51 EUR with a low forecast of 11.54 EUR and a high forecast of 21.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is T3X's stock price target?
Price Target
15.51
EUR
According to Wall Street analysts, the average 1-year price target for T3X is 15.51 EUR with a low forecast of 11.54 EUR and a high forecast of 21.33 EUR.
What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%
The compound annual growth rate for Operating Income over the next 8 years is 41%.
